BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9973204)

  • 1. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma.
    van Lieshout EM; Roelofs HM; Dekker S; Mulder CJ; Wobbes T; Jansen JB; Peters WH
    Cancer Res; 1999 Feb; 59(3):586-9. PubMed ID: 9973204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
    Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
    Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.
    Casson AG; Zheng Z; Porter GA; Guernsey DL
    Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
    Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers.
    Zendehdel K; Bahmanyar S; McCarthy S; Nyren O; Andersson B; Ye W
    Cancer Causes Control; 2009 Dec; 20(10):2031-8. PubMed ID: 19618282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional alterations in the glutathione S-transferase family associated with enhanced occurrence of esophageal carcinoma in China.
    Liu R; Yin L; Pu Y; Li Y; Liang G; Zhang J; Li X
    J Toxicol Environ Health A; 2010; 73(7):471-82. PubMed ID: 20391126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oxidative DNA damage, DNA repair, GSTM1, SOD2 and OGG1 polymorphisms in individual susceptibility to Barrett's esophagus.
    Kadioglu E; Sardas S; Ergun M; Unal S; Karakaya AE
    Toxicol Ind Health; 2010 Mar; 26(2):67-79. PubMed ID: 20056743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility.
    Oude Ophuis MB; Roelofs HM; van den Brandt PA; Peters WH; Manni JJ
    Head Neck; 2003 Jan; 25(1):37-43. PubMed ID: 12478542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma].
    Shao G; Su Y; Huang G; Wen B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):420-3. PubMed ID: 11860825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
    Lin DX; Tang YM; Peng Q; Lu SX; Ambrosone CB; Kadlubar FF
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1013-8. PubMed ID: 9829710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of glutathione S-transferase alpha and pi in human esophageal squamous epithelium, Barrett's epithelium and carcinoma.
    van Lieshout EM; van Haelst UJ; Wobbes T; Peters WH
    Jpn J Cancer Res; 1999 May; 90(5):530-5. PubMed ID: 10391093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer].
    Matthias C; Jahnke V; Fryer AA; Strange RC
    Laryngorhinootologie; 2003 Jan; 82(1):25-30. PubMed ID: 12548461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.